Sanofi to acquire Belgian biotech firm Ablynx for €3.9bn in all-cash deal
French pharmaceutical giant Sanofi has successfully finalized an agreement to acquire Ablynx, a Belgian biotechnology firm, for approximately €3.9 billion. This strategic acquisition surpasses a previous offer of €2.6 billion from Danish pharmaceutical company Novo Nordisk, which Ablynx had rejected citing undervaluation. Details of the Acquisition Ablynx, based in Ghent and established in 2001 as […]